Feasibility of Hepatitis B Vaccination by Microneedle Patch: Cellular and Humoral Immunity Studies in Rhesus Macaques.

BACKGROUND Dissolvable microneedle patches (dMNPs) provide ease of deployment and eliminate need for hypodermic needle disposal after conventional vaccinations. In this study, immunogenicity of dMNP delivery of adjuvant-free monovalent hepatitis B surface antigen (HBsAg) vaccine (AFV) to standard intramuscular (IM) injection of monovalent aluminum-adjuvanted monovalent hepatitis B vaccine (AAV) were compared in rhesus macaques. METHODS Sixteen macaques were immunized twice in 4 groups: dMNP delivery of 24 ± 8µg (n=4) or 48 ± 14µg (n=4) AFV; IM injection of 10µg AFV (IM AFV, n=4); and IM injection of 10µg AAV (IM AAV, n=4). Levels of hepatitis B surface antibody and HBsAg-specific T-cell responses were analyzed. RESULTS Six of 8 animals with dMNP delivery of AFV had anti-HBs levels ≥10 mIU/ml after the first vaccine dose. After dMNP delivery of AFV, IFN-γ, IL-2, and IL-4 production by HBsAg-specific T-cells were detected. A statistically significant positive correlation was detected between anti-HBs levels and HBsAg-specific IFN-γ and IL-2 (Th1-type cytokine) and IL-4 (Th2-type cytokine) producing cells in all anti-HBs positive animals. CONCLUSIONS dMNP delivery of AFV can elicit seroprotective anti-HBs levels in rhesus macaques that correlate in human seroprotection, and could be particularly promising for hepatitis B vaccine birth dose delivery in resource-constrained regions.

• Publication year

  2019

• Venue

  Journal of Infectious Diseases

• Publication date

  2019-08-13

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/infdis/jiz399PMID 31408163PMCID PMC6834072
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hepatitis B vaccination using a dissolvable microneedle patch is immunogenic in mice and rhesus macaques

  2018cited by this paper
• Inactivated rotavirus vaccine by parenteral administration induces mucosal immunity in mice

  2018cited by this paper
• The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised, partly blinded, placebo-controlled, phase 1 trial.

  2017cited by this paper
• Hepatitis B vaccines: WHO position paper – July 2017.

  2017cited by this paper
• Microneedles for vaccine delivery: challenges and future perspectives.

  2017cited by this paper
• Dissolving Microneedle Patches for Dermal Vaccination

  2017cited by this paper
• Engineering Microneedle Patches for Vaccination and Drug Delivery to Skin.

  2017cited by this paper
• Epidemiology of Hepatitis B Virus Infection and Impact of Vaccination on Disease.

  2016influential reference
• Microneedle patches for vaccination in developing countries.

  2016cited by this paper
• The success of microneedle-mediated vaccine delivery into skin

  2016cited by this paper
• Inactivated polio vaccination using a microneedle patch is immunogenic in the rhesus macaque.

  2015cited by this paper
• Kinetics of the inflammatory response following intramuscular injection of aluminum adjuvant.

  2013cited by this paper
• Local Response to Microneedle-Based Influenza Immunization in the Skin

  2012cited by this paper
• Evaluating functional antibodies in rhesus monkeys immunized with hepatitis B virus surface antigen vaccine with novel adjuvant formulations.

  2011cited by this paper
• Aluminum adjuvants elicit fibrin-dependent extracellular traps in vivo.

  2010cited by this paper
• Advances in transcutaneous vaccine delivery: do all ways lead to Rome?

  2010cited by this paper
• Protective Anti-Hepatitis B Virus Responses in Rhesus Monkeys Primed with a Vectored Measles Virus and Boosted with a Single Dose of Hepatitis B Surface Antigen

  2009cited by this paper
• Efficacy of hepatitis B vaccine against antiviral drug‐resistant hepatitis B virus mutants in the chimpanzee model

  2009cited by this paper
• Vaccine site inflammation potentiates idiotype DNA vaccine-induced therapeutic T cell-, and not B cell-, dependent antilymphoma immunity.

  2009cited by this paper
• Aluminum granuloma after administration of the quadrivalent human papillomavirus vaccine. Report of a case.

  2008cited by this paper
• Comparison of Two Hepatitis B Vaccines (GeneVac-B and Engerix-B) in Healthy Infants in India

  2006influential reference
• A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults.

  2006cited by this paper
• MIP-1α, MIP-1β, RANTES, and ATAC/lymphotactin function together with IFN-γ as type 1 cytokines

  2002cited by this paper
• Lymphocyte traffic control by chemokines

  2001cited by this paper
• Chemokines and cell migration in secondary lymphoid organs.

  1999cited by this paper
• Epidermal Langerhans cells: from neurons to nature's adjuvants.

  1999cited by this paper
• Langerhans cells require signals from both tumour necrosis factor‐α and interleukin‐1β for migration

  1997cited by this paper
• The influence of age on the development of the hepatitis B carrier state

  1993cited by this paper
• Vertical transmission of hepatitis B antigen in Taiwan.

  1975cited by this paper
• Reprints Available Directly from the Publisher Photocopying Permitted by License Only Langerhans Cell Migration in Murine Cutaneous Leishmaniasis: Regulation by Tumor Necrosis Factor Interleukin-l/3, and Macrophage Inflammatory Protein

  year unknowncited by this paper

• Recent progress of microneedles in transdermal immunotherapy: A review.

  2024cites this paper
• Microneedle Transdermal Patches- A Novel Painless Approach with Improved Bioavailability for the Treatment of Diseases with Special Prevalence to Neonatal Infection.

  2024cites this paper
• Promising role of microneedles in therapeutic and biomedical applications

  2023cites this paper
• Hepatitis B vaccine delivered by microneedle patch: Immunogenicity in mice and rhesus macaques

  2023cites this paper
• Adverse reactions to cosmetic implants after COVID‐19 vaccination: A literature review

  2023cites this paper
• Folic acid supplementation in pregnant women with hepatitis B surface antigen improves infant hepatitis B surface antibody mediated by infant IL-4

  2022cites this paper
• Evaluation of efficacy and safety of intradermal delivery of vaccines through microneedle(s) in human beings: a protocol for a systematic review

  2022cites this paper
• Microneedle Transdermal Drug Delivery Systems for Allergen-Specific Immunotherapy, Skin Disease Treatment, and Vaccine Development

  2022cites this paper
• Fabricating High-Resolution and High-Dimensional Microneedle Mold through the Resolution Improvement of Stereolithography 3D Printing

  2022cites this paper
• Research hotspot and trend of microneedles in biomedical field: A bibliometric analysis from 2011 to 2020.

  2022cites this paper
• Evaluating the potential cost-effectiveness of microarray patches to expand access to hepatitis B birth dose vaccination in low-and middle-income countries: A modelling study

  2022cites this paper
• Microneedle Array Patches for the Delivery of Therapeutic Agents

  2021cites this paper
• Therapeutic applications of transdermal microneedles.

  2021cites this paper
• Recent Advances in Nanotechnology for the Treatment of Melanoma

  2021cites this paper
• Nanomedicines and microneedles: a guide to their analysis and application.

  2021cites this paper
• Microneedle-Mediated Vaccination: Innovation and Translation.

  2021cites this paper
• Advances in understanding the role of P-gp in doxorubicin resistance: molecular pathways, therapeutic strategies, and prospects.

  2021cites this paper
• Microneedles enable the development of skin-targeted vaccines against coronaviruses and influenza viruses

  2021cites this paper
• The Importance of Nanocarrier Design and Composition for an Efficient Nanoparticle-Mediated Transdermal Vaccination

  2021cites this paper
• Opportunities for biomaterials to address the challenges of COVID‐19

  2020cites this paper
• Vaccination into the Dermal Compartment: Techniques, Challenges, and Prospects

  2020cites this paper
• Emerging skin-targeted drug delivery strategies to engineer immunity: A focus on infectious diseases

  2020cites this paper
• Dextran methacrylate hydrogel microneedles loaded with doxorubicin and trametinib for continuous transdermal administration of melanoma.

  2020cites this paper
• Progress in microneedle array patch (MAP) for vaccine delivery

  2020cites this paper